Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients.

Molecular genetics and metabolism - 1 Jan 2000

Kang Eun Seok, Park Se Eun, Han Seung Jin, Kim So Hun, Nam Chung Mo, Ahn Chul Woo, Cha Bong Soo, Kim Kyung Sub, Lee Hyun Chul

Abstract excerpt

Lipin1 protein, a product of the LPIN1 gene, is required for normal adipose tissue development and metabolism. Lipin1 deficiency results in immature adipocyte development in cases of mouse fatty liver dystrophy and human lipodystrophy. Recently, pioglitazone has been reported to increase human ad...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to Diabetes Mellitus, Type 2
Share to Glycated Hemoglobin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Linkage Disequilibrium

Share to Phosphatidate Phosphatase

Share to Rosiglitazone

Share to Thiazolidinediones

Source

Identifiers

PMID: 18693052
DOI: 10.1016/j.ymgme.2008.06.011

Genes

LPIN1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-18693052-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients.PMID 18693052Read ↗

Adiponectin gene polymorphism rs2241766 T/G is associated with response to pioglitazone treatment in type 2 diabetic patients from southern China.Semantic proximity Read ↗

The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes.Semantic proximity Read ↗

The associations of LPIN1 gene expression in adipose tissue with metabolic phenotypes in the Chinese population.Semantic proximity Read ↗

Impact of genetic polymorphisms of leptin and TNF-α on rosiglitazone response in Chinese patients with type 2 diabetesSemantic proximity Read ↗

Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.Semantic proximity Read ↗

Sequence variation in PPARG may underlie differential response to troglitazone.Semantic proximity Read ↗

Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.Semantic proximity Read ↗

Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus.Semantic proximity Read ↗

Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients.Semantic proximity Read ↗

Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response.Semantic proximity Read ↗

Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes.Semantic proximity Read ↗

Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.